Not quite a myriad of gene patents

Since the early 1980s the United States Patent and Trademark Office (USPTO) has issued patents on inventions involving isolated DNA and RNA molecules with unique functionalities in living systems based on the sequence of nucleotides that make up the molecule2, providing perhaps a better option to gu...

Full description

Saved in:
Bibliographic Details
Published inNature biotechnology Vol. 31; no. 5; pp. 404 - 410
Main Authors Graff, Gregory D, Phillips, Devon, Lei, Zhen, Oh, Sooyoung, Nottenburg, Carol, Pardey, Philip G
Format Journal Article
LanguageEnglish
Published New York Nature Publishing Group US 01.05.2013
Nature Publishing Group
Subjects
631/92/610
706/648/270
Agriculture
Bioinformatics
Biomedical Engineering/Biotechnology
Biomedicine
Biotechnology
Deoxyribonucleic acid
DNA
Drug Industry - legislation & jurisprudence
Drug Industry - statistics & numerical data
Genes
Genetics - legislation & jurisprudence
Genetics - statistics & numerical data
Inventions
Life Sciences
Patents as Topic - legislation & jurisprudence
Patents as Topic - statistics & numerical data
Supreme Court Decisions
United States
United States
Online AccessGet full text

Cover

More Information
Summary:Since the early 1980s the United States Patent and Trademark Office (USPTO) has issued patents on inventions involving isolated DNA and RNA molecules with unique functionalities in living systems based on the sequence of nucleotides that make up the molecule2, providing perhaps a better option to guard genetic innovations than 18th century Piedmonts threat of death. However, patents claiming DNA molecules with nucleotide sequences that correspond directly to coding regions from the genomes of natural organisms.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1087-0156
1546-1696
1546-1696
DOI:10.1038/nbt.2568